Yueting Li Selected Research

Yueting Li Research Topics

Disease

5	Neoplasms (Cancer) 11/2021 - 01/2017
3	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2022 - 01/2019
2	Acne Vulgaris 01/2021 - 01/2020
2	Synovitis 01/2021 - 01/2020
2	Osteitis 01/2021 - 01/2020
2	Hyperostosis 01/2021 - 01/2020
2	Reperfusion Injury 07/2020 - 09/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2018 - 09/2016
2	Alzheimer Disease (Alzheimer's Disease) 02/2014 - 09/2013
1	Neuroinflammatory Diseases 10/2022
1	Cognitive Dysfunction 10/2022
1	Non-alcoholic Fatty Liver Disease 09/2022
1	Fibrosis (Cirrhosis) 09/2022
1	Inflammation (Inflammations) 09/2022
1	Rheumatic Diseases (Rheumatism) 06/2022
1	Asthma (Bronchial Asthma) 03/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 11/2021
1	Cryptococcosis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Osteolysis 11/2020
1	Dyspnea (Shortness of Breath) 10/2020
1	Drug-Related Side Effects and Adverse Reactions 10/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2020
1	Heart Failure 03/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Arteriosclerosis 01/2020
1	Rheumatoid Arthritis 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Gallstones (Gallstone) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Pyelonephritis 10/2019
1	Carcinoma (Carcinomatosis) 03/2019
1	Pulmonary Edema 01/2019
1	Acute Lung Injury 01/2019
1	Vascular Diseases (Vascular Disease) 07/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2017

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 06/2022 - 01/2017
3	CytokinesIBA 09/2022 - 01/2020
3	tofacitinibIBA 01/2022 - 01/2020
3	salicylhydroxamic acid (SHAM)IBA 07/2020 - 09/2016
2	OvalbuminIBA 03/2022 - 10/2020
2	Circular RNAIBA 11/2021 - 01/2020
2	EnzymesIBA 10/2020 - 09/2013
2	quercitrinIBA 07/2020 - 10/2019
2	scutellarinIBA 07/2018 - 09/2016
1	p38 Mitogen-Activated Protein KinasesIBA 10/2022
1	shengyuIBA 10/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022
1	CeramidesIBA 09/2022
1	Messenger RNA (mRNA)IBA 09/2022
1	alpha2 Subunit Collagen Type IIBA 09/2022
1	Choline (Choline Chloride)IBA 09/2022
1	Interleukin-6 (Interleukin 6)IBA 09/2022
1	Methionine (L-Methionine)FDA Link 09/2022
1	Cytidine Diphosphate (CDP)IBA 06/2022
1	Immunoglobulin E (IgE)IBA 03/2022
1	Interleukin-13IBA 03/2022
1	Interleukin-5 (Interleukin 5)IBA 03/2022
1	SeleniumIBA 01/2022
1	Cadherins (E-Cadherin)IBA 11/2021
1	VimentinIBA 11/2021
1	Small Interfering RNA (siRNA)IBA 11/2021
1	Plant Preparations (Preparation, Plant)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Fluconazole (Zonal)FDA LinkGeneric 01/2021
1	Diphosphonates (Bisphosphonates)IBA 11/2020
1	ChemokinesIBA 10/2020
1	afzelinIBA 07/2020
1	taxifolinIBA 07/2020
1	astragalinIBA 07/2020
1	qishen granuleIBA 03/2020
1	human MIRN-2682 microRNAIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	lidanIBA 01/2020
1	AntioxidantsIBA 01/2020
1	CholesterolIBA 01/2020
1	Lipid PeroxidesIBA 01/2020
1	LipidsIBA 01/2020
1	HDL CholesterolIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2020
1	protocatechuic acidIBA 10/2019
1	Gallic AcidIBA 10/2019
1	Peptide LibraryIBA 03/2019
1	Peptides (Polypeptides)IBA 03/2019
1	ferric ferrocyanide (Prussian blue)FDA Link 03/2019
1	LipopolysaccharidesIBA 01/2019
1	Technetium Tc 99m MedronateIBA 01/2019
1	scutellareinIBA 07/2018
1	Chlorogenic AcidIBA 07/2018
1	shenxiong glucoseIBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017

Therapy/Procedure

2	Oral Administration 07/2020 - 10/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2018 - 11/2017
1	Off-Label Use 01/2022